The Goldman Sachs Group, Inc. 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 4:52 pm Sale | 2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | GOLDMAN SACHS GROUP INC GS | 2,007,447 2.500% | -1,828,712 (-47.67%) | Filing |
| 2023-02-08 09:52 am Purchase | 2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | GOLDMAN SACHS GROUP INC GS | 3,836,159 5.700% | 212,914 (+5.88%) | Filing |
| 2022-02-02 1:03 pm Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | GOLDMAN SACHS GROUP INC GS | 3,623,245 6.200% | 3,623,245 (New Position) | Filing |